The French medicines regulator, ANSM, is proposing to require the outer packaging of all medicines to carry a new pictogram showing the likelihood of teratogenicity or fetotoxicity if they are taken during pregnancy.
The risks displayed by the new pictograms would also take account of the likelihood of neurodevelopmental problems in the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?